|
Age of diagnosis (years [mean ± SEM])
|
29.6 ± 3.05
|
|
Disease duration (years [mean ± SEM])
|
14.93 ± 3.17
|
|
Infectious onset, n(%)
|
13 (86.7%)
|
|
Cognitive difficulties
|
|
Yes
|
15 (100%)
|
|
No
|
0 (0%)
|
|
Pain
|
|
Yes
|
15 (100%)
|
|
No
|
0 (0%)
|
|
Sleep disturbances
|
|
Yes
|
15 (100%)
|
|
No
|
0 (0%)
|
|
Sensory disturbances
|
|
Yes
|
15 (100%)
|
|
No
|
0 (0%)
|
|
Immune disturbances
|
|
Yes
|
14 (93.3%)
|
|
No
|
1 (6.7%)
|
|
Gastrointestinal disturbances
|
|
Yes
|
14 (93.3%)
|
|
No
|
1 (6.7%)
|
|
Cardiovascular disturbances
|
|
Yes
|
15 (100%)
|
|
No
|
0 (0%)
|
|
Respiratory disturbances
|
|
Yes
|
8 (53.3%)
|
|
No
|
7 (46.7%)
|
|
Thermostatic instability
|
|
Yes
|
11 (73.3%)
|
|
No
|
4 (26.7%)
|
|
Urinary disturbances
|
|
Yes
|
5 (33.3%)
|
|
No
|
10 (66.7%)
|
- ME Myalgic encephalomyelitis, CFS chronic fatigue syndrome, SEM standard error of mean, n number
